Alan Bye



Alan has more than 40 years of experience in senior positions in the pharmaceutical industry (Wellcome, Upjohn, Glaxo), lately as V-P Discovery Medicine for the Psychiatry Centre of Excellence Drug Discovery at GSK.

Alan has been involved with the development of hundreds of compounds, leading to more than 300 first in human studies, and to the successful launch of of more than 40 commercial products.

Alan also has a particular interest in the pre-clinical to clinical translation in the neuroscience and pain, an area in which he also widely published.